Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases Rare Diseases Resources for Refugees/Displaced PersonsSearch for a rare disease
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
A rare familial cardiomyopathy characterized by left ventricular enlargement and/or reduced systolic function preceded or accompanied by significant conduction system disease and/or arrhythmias including bradyarrhythmias, supraventricular or ventricular arrhythmias. Disease onset is usually in early to mid-adulthood. Sudden cardiac death may occur and may be the presenting symptom. In some cases, it is associated with skeletal myopathy.
ORPHA:300751
Classification level: Disorder
Prevalence: Unknown
Inheritance: Autosomal dominant
Age of onset: Adult
Guidelines
Disease review articles
Genetic testing
: produced/endorsed by ERN(s) : produced/endorsed by FSMR(s)
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
- Research project(s) (64)
- Clinical trial(s) (3)
- Biobank(s) (9)
- Registry(ies) (24)
- Network of experts (5)
Newborn screening